Drug Discovery Product Showcase

1. NanoAssemblr™ Ignite And Ignite+ Nanoparticle Formulation Systems 10/21/2026

   The NanoAssemblr™ Ignite and Ignite+ systems provide an easy-to-use, scalable platform for reproducible lipid nanoparticle formulation. Choose the workflow and cartridge-use approach that fits your program today, with a validated path to clinical and commercial manufacturing when you are ready.

2. The Experimental Truth Layer For AI-Native Drug Discovery 9/30/2026

   Protein dynamics can expose critical gaps between computational predictions and biological behavior. Learn how experimentally measuring conformational states can strengthen model validation.

3. Rescuing Proteins With Scalable Insect Expression 9/29/2026

   Overcome protein expression bottlenecks with a scalable insect-based platform that delivers faster development, predictable scale-up, and consistent manufacturing.

4. The EntoEngine: Fruit Flies For Advanced Biomanufacturing 9/27/2026

   Produce recombinant proteins at scale with stable expression, flexible batch sizes, and streamlined manufacturing.

5. Secure Scalable Supply Of Critical Assay Proteins For Diagnostic R&D 9/26/2026

   Our custom expression platform directly addresses the primary host limitations in early-to-mid stage assay development:

6. Quantum-Enabled EPR For Structural Biology And Drug Discovery 9/24/2026

   Capturing dynamic conformational states is key to target druggability. Advanced EPR spectroscopy delivers nanometer-resolution measurements for complex structural biology.

7. Breaking The Limits Of Automated Sample Preparation 9/2/2026

   Automated nucleic acid purification can deliver high throughput without limiting flexibility or consuming valuable bench space. See how adaptable workflows support efficient sample preparation.

8. Hybrid Pipette - Intuitive Manual Control, Rapid Electronic Aliquoting 9/1/2026

   Combine precise manual control with rapid repeat dispensing in one instrument. One-handed volume adjustment, intuitive controls, and flexible charging help streamline liquid handling.

9. Preclinical Genome Editing Risk Assessment Services 8/31/2026

   Regulatory-aligned off-target risk assessment for genome editing programs, from early guide RNA screening through IND-enabling confirmation studies, structured to support FDA submission requirements.

10. Designed For Difficult Biology 6/17/2026

    Macrocycles expand drug discovery into previously inaccessible targets. With validated success and flexible approaches, they provide a powerful path for tackling the most challenging biology.